Carolina Wealth Advisors LLC Sells 7,245 Shares of The Clorox Company $CLX

Carolina Wealth Advisors LLC reduced its position in shares of The Clorox Company (NYSE:CLXFree Report) by 95.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 328 shares of the company’s stock after selling 7,245 shares during the quarter. Carolina Wealth Advisors LLC’s holdings in Clorox were worth $33,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Future Financial Wealth Managment LLC bought a new stake in shares of Clorox during the 4th quarter valued at about $330,000. Inlet Private Wealth LLC bought a new stake in shares of Clorox during the 4th quarter valued at about $784,000. Flagship Harbor Advisors LLC grew its stake in shares of Clorox by 14.8% during the 4th quarter. Flagship Harbor Advisors LLC now owns 2,267 shares of the company’s stock valued at $229,000 after purchasing an additional 292 shares during the period. Beaumont Asset Management L.L.C. grew its stake in shares of Clorox by 13.7% during the 4th quarter. Beaumont Asset Management L.L.C. now owns 4,039 shares of the company’s stock valued at $407,000 after purchasing an additional 488 shares during the period. Finally, Leo Wealth LLC bought a new stake in shares of Clorox during the 4th quarter valued at about $250,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Up 3.8%

NYSE CLX opened at $105.02 on Tuesday. The stock’s 50 day moving average is $114.62 and its 200 day moving average is $111.24. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The Clorox Company has a 12 month low of $96.66 and a 12 month high of $143.96. The stock has a market cap of $12.70 billion, a PE ratio of 17.16, a P/E/G ratio of 0.50 and a beta of 0.65.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the prior year, the firm posted $1.55 earnings per share. The firm’s revenue for the quarter was down .8% on a year-over-year basis. Research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be issued a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, April 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.7%. Clorox’s payout ratio is currently 81.05%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on CLX shares. Rothschild & Co Redburn set a $117.00 price target on Clorox in a research note on Friday, February 13th. TD Cowen boosted their price target on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. BNP Paribas Exane upgraded Clorox from an “underperform” rating to a “neutral” rating in a research note on Wednesday, February 11th. Wells Fargo & Company set a $125.00 price target on Clorox in a research note on Tuesday, February 17th. Finally, Weiss Ratings downgraded Clorox from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of $118.00.

Get Our Latest Analysis on Clorox

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.